v3.26.1
Condensed Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain/(Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   60,860,838      
Beginning balance at Dec. 31, 2024 $ 304,081 $ 6 $ 1,013,806 $ 321 $ (710,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   525,345      
Issuance of common stock under benefit plans 498   498    
Stock-based compensation 8,913   8,913    
Net unrealized loss on short-term investments (162)     (162)  
Net loss (56,166)       (56,166)
Ending balance (in shares) at Mar. 31, 2025   61,386,183      
Ending balance at Mar. 31, 2025 $ 257,164 $ 6 1,023,217 159 (766,218)
Beginning balance (in shares) at Dec. 31, 2025 61,449,290 61,449,290      
Beginning balance at Dec. 31, 2025 $ 181,205 $ 6 1,040,610 (15) (859,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under benefit plans (in shares)   465,279      
Issuance of common stock under benefit plans 74   74    
Stock-based compensation 4,254   4,254    
Net unrealized loss on short-term investments (326)     (326)  
Net loss $ (20,040)       (20,040)
Ending balance (in shares) at Mar. 31, 2026 61,914,569 61,914,569      
Ending balance at Mar. 31, 2026 $ 165,166 $ 6 $ 1,044,937 $ (341) $ (879,436)